Navigation Links
Osiris in Medical News

Former Executive at Genzyme Corp. and Osiris Therapeutics, Inc. to Head Business Advisory Board at Rx for Africa, Inc.

NEW YORK, April 13 /PRNewswire-FirstCall/ -- A top biotech executive, William Pursley, has agreed to become Chairman of Rx for Africa, Inc.'s (Pink Sheets: RXAF) newly created Business Advisory Board. For 25 years Mr. Pursley has held major executive positions in the biotech industry. In 1985 he j...

JDRF Partners with Osiris to evaluate an immunomodulatory cell therapy product for type 1 diabetes

JDRF Partners with Osiris on a Phase II Trial to Evaluate an Immunomodulatory Cell Therapy Product For Type 1 Diabetes New York, NY October 25, 2007 The Juvenile Diabetes Research Foundation announced today a partnership with Osiris Therapeutics, Inc. (NASDAQ:OSIR) to support a Phase II cli...

Biotech Osiris to go public

Baltimore biotech, the company that is known for being the sole manufacturer of the stem cell product, has made its plans known, about its intention to go public//. The company is slated to sell out nearly $80 million in shares, as per the papers filed with the Securities and Exchange Commission. ...

Long Term Supply of Osteocel(R) Plus Solidified Without Ownership of Processing Facility

...Vasive has accelerated the transfer of the processing of Osteocel Plus from osiris Therapeutics (Nasdaq: OSIR ) to its own exclusive supply chain. Sin...and consistent stream of supply. NuVasive will not assume ownership of the osiris tissue processing facility. NuVasive reiterates its previous guidance ...

Ongoing worldwide shortage of medical isotopes could threaten patient care, says expert

...ld's Mo-99 is produced by five commercial nuclear reactors NRU at Chalk River in Canada, HFR at Petten in The Netherland, BR-2 at Fleurus in Belgium, osiris at Saclay in France and SAFARI-1 at Pelindaba in South Africa. The UK has no facility for producing Mo-99 of its own. Until fairly recently, productio...

BullMarket.com Examines Stem Cell Stocks

...ibers with coverage of stem cell stocks, including Geron (Nasdaq: GERN ), osiris Therapeutics (Nasdaq: OSIR ), Cytori Therapeutics (Nasdaq: CYTX ), and ...ptions surrounding stem cell stocks? -- What are some of the positives osiris has going for it? -- What potential problem could Cytori run into? ...

NuVasive Announces Preliminary Unaudited Full Year 2008 Financial Results

...nge of $345 million to $350 million. Osteocel revenue in the fourth quarter 2008 included approximately $5 million in sales to former distributors of osiris Therapeutics, Inc. (Nasdaq: OSIR ). As the Company launches the Osteocel product through its exclusive sales force, it will not have the benefit of...

QRxPharma Expands Management Team with the Addition of Dr. Jesus Soriano as Executive Vice President

...o joining QRxPharma, Soriano was Senior Director of Business Development at osiris Therapeutics, Inc., and responsible for all business development activities... out-licensing and divestiture. During Dr. Soriano's tenure, Maryland-based osiris Therapeutics formed a $1.4 billion partnership with Genzyme Corp. for the d...

Stem Cell Product Commercialization Focus of Summit

...Inc. Novocell, Inc. ArunA Biomedical, Inc. NuVasive, Inc. BioE Corp. osiris Therapeutics, Inc. California Stem Cell, Inc. Progenitor Cell Therapy, Inc. Cellerix, S.A. SpineSmit...

Preliminary Lineup Set for 4th Annual Stem Cell Summit

... Arteriocyte, Inc. Novocell, Inc. BioE Corp. NuVasive, Inc. California Stem Cell, Inc. osiris Therapeutics, Inc. Cellerix, S.A. Progenitor Cell Therapy, Inc. Cognate BioServices, Inc. Stemagen Cytori Ther...
Osiris in Medical Technology

Pain Relief in Just One Visit with Genzyme's Synvisc-One

...ceuticals, Genzyme Biosurgery, Integra LifeSciences, LifeNet Health, Medtronic Spinal and Biologics, Musculoskeletal Transplant Foundation, Orthovita, osiris Therapeutics, Osteotech, RTI Biologics, sanofi-aventis, Smith & Nephew, Stryker, Synthes, Wright Medical Technology, and many more. Other reports ...

Heart Attack Patients Treated With Novel Stem Cell Therapy Experience Significant Improvement in Heart and Lung Function

...dical Center, we were able to conduct a study that was exceptionally well planned and executed” said C. Randal Mills Ph.D., President and CEO of osiris Therapeutics. “We were confident in the safety profile given our previous experience using the intravenous form of these stem cells to treat oth...
Osiris in Medical Products

Osiris

Description:... osiris is a system built around data management software and an imaging device that measures the inhibition zone size around an antibiotic disc. osiris offers built-in expertise for detection of potential errors and detection o...
Company:Bio-Rad Laboratories
Osiris in Biological News

Stem cell therapy shows promise in regenerating damaged muscle in heart attack patients

...em cells pre-formulated for intravenous delivery by the drug's manufacture, osiris Therapeutics. Patients were administered an infusion of either Provacel or...well planned and executed" said C. Randal Mills Ph.D., President and CEO of osiris Therapeutics. "We were confident in the safety profile given our previous e...
Osiris in Biological Technology

NuVasive Signs Definitive Agreement to Acquire Osteocel Biologics Business from Osiris Therapeutics

- Expands biologics platform for robust growth - - Includes proprietary adult stem cell bone graft product and processing facility - - Expects Osteocel(R) revenues of $15 million in 2008 and $25 million in 2009; no dilution to earnings per share in...

NeoStem Featured in Business Week; 'Promising' Adult Stem Cell Market Discussed in Fortune-CNNMoney.com Article

...tal Partners, a Pan-Asian private equity firm with deep connections across Asia, declared, "I believe investors are beginning to see that, compared to osiris -- which is the largest stem cell company with a market cap of around $425 million -- NBS is dramatically undervalued given its IP portfolio, product ...

AssureRx Adds New CEO

... the buyout of a New York Stock Exchange company to form MedPointe Pharmaceuticals. Mr. Burns was also a founder, chairman, president and CEO of osiris Therapeutics Inc., a public biotech company developing therapeutic stem-cell products for the regeneration of damaged or diseased tissues. Previously,...

Heart Hospital of Austin First Site in World to Test Efficacy of New Adult Stem Cell Therapy to Treat Damaged Heart Tissue in Phase II Trial

...o or animal. MSCs have the ability to develop into other types of cells and generate new tissue, including heart muscle. Prochymal(R) is a product of osiris Therapeutics, Inc. "There's a lot of enthusiasm in the cardiovascular community about the potential of stem cell therapies for treating heart dis...

Three Firms, Two Training Programs Garner Greater Baltimore Committee's 2009 Bioscience Awards

... Best New Product or Progress: C. Randal Mills, Ph.D., president and CEO, osiris Therapeutics, Inc. Mills' Columbia-based company has spent more than $300 million developing stem cell therapies. The funding has allowed osiris to complete clinical trials necessary to demonstrate the safety and efficac...

Greater Baltimore Committee to Announce Winners of 2009 Maryland Bioscience Awards at Ceremonies on March 12

...agement Corporation Fred E. Festa , chairman, president and CEO, W.R. Grace & Company Dr. C. Randal Mills , president and CEO, osiris Therapeutics, Inc. Dr. Bruce Thompson , chairman of the board and president, Clinical Trials and Surveys Corp. (C-TASC) Lea...

NuVasive Completes Acquisition of Osteocel Biologics Business

... surgical treatments for the spine, announced today that it has completed the previously announced acquisition of the Osteocel biologics business from osiris Therapeutics, Inc. (Nasdaq: OSIR ) for $35 million in cash, plus additional milestone-based contingent payments not to exceed $50 million in either c...

BioSpace Career Fair in Bethesda, Maryland Draws Hundreds of Industry Professionals

... biologists, chemists and many others attended to interview with some of the top biotechnology companies and pharmaceutical firms. Companies including osiris Therapeutics and SAIC-Frederick were hiring for biotech business development careers, pharmaceutical facility management jobs, cell biology careers, b...

Stem Cell Therapy to Skyrocket by 2017

...dvanced Cell Technologies, Arteriocyte, Blackstone Medical, Cytori Therapeutics, Geron, Harvest Technologies, International Stem Cell Corporation, and osiris Therapeutics. About Stem Cells Stem cells are primal cells that are derived from highly proliferative tissues. These cells are precursors to every o...
Other Tags
(Date:10/28/2014)... that aims to make personalized medicine a reality for ... across British Columbia. , The "Genomics for Precision Drug ... of its kind in North America. The project is ... (BCPhA), with the research component led by a team ... Sciences (UBC). It will position the pharmacist as the ...
(Date:10/27/2014)... price tag for informal caregiving of elderly people by ... $522 billion a year, according to a new RAND ... care at minimum wage would cost $221 billion, while ... $642 billion annually. , The study, published online ... estimates about the value of informal caregiving by making ...
(Date:10/27/2014)... different role than previously thought in the opening and ... out of our cells, researchers at Johns Hopkins report. ... right concentrations of sodium and calcium ions in cells ... processes. The new study reveals that a form of ... channels wide. The finding is likely to bring new ...
(Date:10/27/2014)... The 2014 Sharp­Brains Vir­tual ... world’s top sci­en­tists and inno­va­tors work­ing on ... via neuroscience-based inno­va­tion. , Indi­vid­u­als and insti­tu­tions ... bil­lion in 2014 in web-based, mobile and ... func­tion. Growth is poised to con­tinue, fueled ...
(Date:10/27/2014)... Agency (EMA), an EU agency, has gathered information on ... European ADR database, EudraVigilance. Both authorities and pharmaceutical companies ... the database, which provides new knowledge about unknown and ... drug reaction reports on asthma medications approved for – ... (2007 to 2011). In the light of the total ...
Breaking Medicine News(10 mins):Health News:Genomics helps pharmacists target the right drugs for the right patient 2Health News:Cost of informal caregiving for US elderly is $522 billion annually, study finds 2Health News:200 Experts to Discuss and Shape the Future of Brain Health, Gathered Around a Virtual Table 2Health News:200 Experts to Discuss and Shape the Future of Brain Health, Gathered Around a Virtual Table 3Health News:200 Experts to Discuss and Shape the Future of Brain Health, Gathered Around a Virtual Table 4Health News:Adverse drug reactions in children following use of asthma medications 2
(Date:10/29/2014)... EAST LANSING, Mich. – As bodies decompose, their ... Deciphering the clues they provide could mean the ... murder. , Michigan State University is using a ... to help Detroit death-scene investigators examine these changing ... such as geographical location of death, gender, race, ...
(Date:10/29/2014)... Virtually all organisms in the living world compete ... differ strongly in how much they invest into ... and eager to get access to high-quality resources, ... prudent use of the lower-quality resources that are ... competitiveness in animal and human societies seems to ...
(Date:10/28/2014)... news release is available in German . ... close relatives, the chimpanzees, acquire sufficient food when times ... National Park in Côte d,Ivoire researchers of the Max ... a clear example of how great apes can acquire ... show that chimpanzees make their sleeping nests more en ...
Breaking Biology News(10 mins):MSU partners with Detroit to investigate death scenes 2Evolution of competitiveness 2Evolution of competitiveness 3The early chimp gets the fig 2The early chimp gets the fig 3
Other Contents